Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (otvara se novi prozor)

Ball AM, Winstead PS.

Izvor‎: Pharmacotherapy 2008;28(11):1383-90.

Indeks‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (otvara se novi prozor)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (otvara se novi prozor)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Izvor‎: Transplant Proc 2015;47(8):2548-51.

Indeks‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (otvara se novi prozor)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (otvara se novi prozor)

Charles A, Purtill M, Napolitano LM.

Izvor‎: Anaesth Intensive Care 2006;34(6):793-6.

Indeks‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (otvara se novi prozor)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (otvara se novi prozor)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Izvor‎: Crit Care Med 1999;27(11):2346-50.

Indeks‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (otvara se novi prozor)

The role of erythropoietin therapy in the critically ill. (otvara se novi prozor)

Corwin HL.

Izvor‎: Transfus Med Rev 2006;20(1):27-33.

Indeks‎: PubMed 16373185

DOI‎: 10.1016/j.tmrv.2005.08.002

https://www.ncbi.nlm.nih.gov/pubmed/16373185 (otvara se novi prozor)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (otvara se novi prozor)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Izvor‎: Crit Care 2005;9(5):R508-15.

Indeks‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (otvara se novi prozor)

Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. (otvara se novi prozor)

Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, Gray Z, Khelgi V, Robertson IK, Kirkby BP.

Izvor‎: Lancet Haematol 2016;3(9):e415-25.

Indeks‎: PubMed 27570088

DOI‎: 10.1016/S2352-3026(16)30078-3

https://www.ncbi.nlm.nih.gov/pubmed/27570088 (otvara se novi prozor)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (otvara se novi prozor)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Izvor‎: Intensive Care Med 2013;39(11):1896-908.

Indeks‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (otvara se novi prozor)

An international consensus statement on the management of postoperative anaemia after major surgical procedures. (otvara se novi prozor)

Muñoz M, Acheson AG, Bisbe E, Butcher A, Gómez-Ramírez S, Khalafallah AA, Kehlet H, Kietaibl S, Liumbruno GM, Meybohm P, Rao Baikady R, Shander A, So-Osman C, Spahn DR, Klein AA

Izvor‎: Anaesthesia 2018;73(11):1418-31.

Indeks‎: PubMed 30062700

DOI‎: 10.1111/anae.14358

https://www.ncbi.nlm.nih.gov/pubmed/30062700 (otvara se novi prozor)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (otvara se novi prozor)

Posluszny JA Jr, Napolitano LM.

Izvor‎: Transfusion 2014;54(12):3026-34.

Indeks‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (otvara se novi prozor)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (otvara se novi prozor)

Price S, Pepper JR, Jaggar SI.

Izvor‎: Anesth Analg 2005;101(2):325-7.

Indeks‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (otvara se novi prozor)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (otvara se novi prozor)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Izvor‎: J Am Heart Assoc 2015;4(6):e002066.

Indeks‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (otvara se novi prozor)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (otvara se novi prozor)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Izvor‎: Br J Anaesth 2005;94(4):442-4.

Indeks‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (otvara se novi prozor)

Transfusion-free management of gastrointestinal bleeding: the experience of a Bloodless Institute. (otvara se novi prozor)

Sharma P, Barajas FJ, Krishnamoorthy P, Campo LM, Blumenthal E, Spinnell M.

Izvor‎: J Clin Gastroenterol 2015;49(3):206-11.

Indeks‎: PubMed 25144897

DOI‎: 10.1097/MCG.0000000000000200

https://www.ncbi.nlm.nih.gov/pubmed/25144897 (otvara se novi prozor)

Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. (otvara se novi prozor)

Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.

Izvor‎: Crit Care Med 2006;34(9):2310-6.

Indeks‎: PubMed 16878035

DOI‎: 10.1097/01.CCM.0000233873.17954.42

https://www.ncbi.nlm.nih.gov/pubmed/16878035 (otvara se novi prozor)